Synergistic Heterozygosity in Rare Digenic Hereditary Anemias Accurately Diagnosed by whole Exome Sequencing
Article Sidebar
Main Article Content
Article Details
Copyright (c) 2025 Angel-Rodríguez F, et al.
This work is licensed under a Creative Commons Attribution 4.0 International License.
The Archives of Case Reports is committed in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. In order to use the Open Access paradigm to the maximum extent in true terms as free of charge online access along with usage right, we grant usage rights through the use of specific Creative Commons license.
License: Copyright © 2017 - 2025 | 
Open Access by Archives of Case Reports is licensed under a Creative Commons Attribution 4.0 International License. Based on a work at Heighten Science Publications Inc.
With this license, the authors are allowed that after publishing with the journal, they can share their research by posting a free draft copy of their article to any repository or website.
Compliance 'CC BY' license helps in:
| Permission to read and download | ✓ |
| Permission to display in a repository | ✓ |
| Permission to translate | ✓ |
| Commercial uses of manuscript | ✓ |
'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.
Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.
1. Piel FB, Steinberg MH, Rees DC. Sickle Cell Disease. New England Journal of Medicine. 2017 Apr 20;376(16):1561–73.
2. Onimoe G, Rotz S. Sickle cell disease: A primary care update. CCJM. 2020 Jan 1;87(1):19–27.
3. Fong C, Lizarralde-Iragorri MA, Rojas-Gallardo D, Barreto G. Frequency and origin of haplotypes associated with the beta-globin gene cluster in individuals with trait and sickle cell anemia in the Atlantic and Pacific coastal regions of Colombia. Genet Mol Biol. 2013 Dec;36(4):494–7.
4. Kato GJ, Piel FB, Reid CD, Gaston MH, Ohene-Frempong K, Krishnamurti L, et al. Sickle cell disease. Nat Rev Dis Primers. 2018 Mar 15;4(1):1–22.
5. Pinto VM, De Franceschi L, Gianesin B, Gigante A, Graziadei G, Lombardini L, et al. Management of the Sickle Cell Trait: An Opinion by Expert Panel Members. J Clin Med. 2023 May 12;12(10):3441.
6. Zanella A, Bianchi P, Fermo E. Pyruvate kinase deficiency. Haematologica. 2007 Jun 1;92(6):721–3.
7. Manco L, Vagace JM, Relvas L, Rebelo U, Bento C, Villegas A, et al. Chronic haemolytic anaemia because of pyruvate kinase (PK) deficiency in a child heterozygous for haemoglobin S and no clinical features of sickle cell disease. Eur J Haematol. 2010 Jan 1;84(1):89–90.
8. Alli N, Coetzee M, Louw V, van Rensburg B, Rossouw G, Thompson L, et al. Sickle cell disease in a carrier with pyruvate kinase deficiency. Hematology. 2008 Dec;13(6):369–72.
9. Cohen-Solal M, Préhu C, Wajcman H, Poyart C, Bardakdjian-Michau J, Kister J, et al. A new sickle cell disease phenotype associating Hb S trait, severe pyruvate kinase deficiency (PK Conakry), and an alpha2 globin gene variant (Hb Conakry). Br J Haematol. 1998 Dec;103(4):950–6.
10. Risinger M, Christakopoulos GE, Schultz CL, McGann PT, Zhang W, Kalfa TA. Hereditary elliptocytosis-associated alpha-spectrin mutation p.L155dup as a modifier of sickle cell disease severity. Pediatr Blood Cancer. 2019 Feb;66(2):e27531.
11. Ustun C, Kutlar F, Holley L, Seigler M, Burgess R, Kutlar A. Interaction of sickle cell trait with hereditary spherocytosis: splenic infarcts and sequestration. Acta Haematol. 2003;109(1):46–9.
12. Vockley J, Rinaldo P, Bennett MJ, Matern D, Vladutiu GD. Synergistic heterozygosity: disease resulting from multiple partial defects in one or more metabolic pathways. Mol Genet Metab. 2000;71(1–2):10–8.
13. Naik RP, Haywood C. Sickle cell trait diagnosis: clinical and social implications. Hematology Am Soc Hematol Educ Program. 2015;2015(1):160–7.
14. Tubman VN, Field JJ. Sickle solubility test to screen for sickle cell trait: what’s the harm? Hematology Am Soc Hematol Educ Program. 2015;2015:433–5.
15. Benson JM, Therrell BL. History and current status of newborn screening for hemoglobinopathies. Semin Perinatol. 2010 Apr;34(2):134–44.